Congress is on the verge of passing historic drug pricing legislation that would allow the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift those costs to the private market.
The reconciliation package the Senate passed Sunday includes drug pricing provisions that Democrats have been pushing for decades, including a framework for Medicare to negotiate prices directly with manufacturers, limit price increases to inflation and cap out-of-pocket drug costs for consumers.
The bill received no Republican votes in the Senate and isn’t expected to when the House votes on it on Friday.
